• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number UNK LINX MAGNETIC IMPLANT
Device Problems Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problems Dehydration (1807); Dysphagia/ Odynophagia (1815); Unspecified Infection (1930); Nausea (1970); Paresis (1998); Pneumonia (2011); Vomiting (2144); Cramp(s) /Muscle Spasm(s) (4521)
Event Date 06/16/2023
Event Type  Injury  
Event Description
It was reported via journal article: title: the impact of delayed gastric emptying as measured by gastric emptying scintigraphy on the outcome of magnetic sphincter augmentation.Authors: sven e.Eriksson · ping zheng · inanc s.Sarici · xinxin shen · blair a.Jobe · shahin ayazi.Citation: surgical endoscopy (2023) 37:7144¿7152 https://doi.Org/10.1007/s00464-023-10190-y.The objective of this study is to evaluate the relationship between objective delayed gastric emptying (dge) and magnetic sphincter augmentation (msa) outcomes over time.Between 2013 and 2021, a total of 775 patients who underwent magnetic sphincter augmentation (msa).Patients with gerd who were 18 years or older with no history of prior foregut surgery who completed preoperative ges and had at least 1 year follow-up were included in this study.The median (iqr) age was 55.7 (44.9¿62.9) and bmi was 29.1 (26.8¿33.1).There were 26 (19.8%) patients with delayed gastric emptying (dge) and 105 patients with nge on gastric emptying scintigraphy (ges).During the initial 90 days after surgery 5 patients with dge and 3 patients with nge required readmission to the hospital.The indications for readmissions in dge group were severe dysphagia, complicated by poor oral intake and dehydration, all successfully managed with fluid resuscitation and endoscopic dilation (n=4) and surgical site infection (n=1).The indications for readmissions in the nge group were nausea and vomiting with dehydration, managed conservatively (n= 1), pneumonia (n=1) and severe esophageal spasm, which was managed with endoscopic dilation (n=1).The linx device (ethicon, johnson & johnson; shoreview, mn) is an expandable bracelet of titanium beads with magnetic cores that is placed around the esophagus at the esophagogastric junction (egj).The msa is manufactured in different sizes, ranging from 13 to 17 beads.A manufacturer provided sizing device that measures the circumference in number of beads is used to assist in the selection of the appropriately sized device.Reported complications included for dge/delayed gastric emptying (n=5); severe dysphagia, complicated by poor oral intake and dehydration, surgical site infection (n=1) and for nge/normal gastric emptying (n=3); nausea and vomiting with dehydration, pneumonia (n=1), severe esophageal spasm.In conclusion, outcomes after msa are diminished early on in patients with mild-to-moderate dge, but comparable by 1 year and durable at 2 years.Severe dge outcomes may be suboptimal.
 
Manufacturer Narrative
(b)(4).Date sent: 4/10/2024.This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot/batch number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: does the author/surgeon believe that the ethicon device caused or contributed to the patient complications mentioned in the article? if yes, please explain.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK LINX MAGNETIC IMPLANT
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4545 creek road
cincinnati OH
Manufacturer Contact
kate karberg
4545 creek rd.
cincinnati, OH 45242
3035526892
MDR Report Key19079228
MDR Text Key339877280
Report Number3008766073-2024-00060
Device Sequence Number1
Product Code LEI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 04/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK LINX MAGNETIC IMPLANT
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/28/2024
Initial Date FDA Received04/10/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-